Home » OKLAHOMA COMPANY CHOSEN TO LAUNCH THYROID DISEASE RAPID DETECTION DEVICE APPROVED BY FDA
OKLAHOMA COMPANY CHOSEN TO LAUNCH THYROID DISEASE RAPID DETECTION DEVICE APPROVED BY FDA
Oklahoma City, Okla.-based American Health Partners Oklahoma was chosen by ThyroTec, a New Jersey-based medical products development company, to launch a presence in the market, establish brand equity, finalize product packaging and develop and implement all sales and distribution functions for ThyroTest, a new FDA approved, CLIA waived rapid hypothyroid diagnostic screening device.
Yahoo News (http://biz.yahoo.com/prnews/041230/lath002_1.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct